IFI44 and prostate adenocarcinoma: The results from GEPIA (Supplementary Figure 2) exhibited that IFI44-high expression group was significantly associated with shorter OS and DFS compared with IFI44-low expression group in HNSC (P = 0.022 and HR = 1.5 for DFS), brain lower grade glioma (LGG) (P = 2.1e−07 and HR = 2.6 for OS; P = 5.1e−06 and HR = 2 for DFS), prostate adenocarcinoma (PRAD) (P = 0.0035 and HR = 1.9 for DFS), uveal melanoma (UVM) (P = 0.026 and HR = 2.8 for OS; P = 0.031 and HR = 2.8 for DFS), thymoma (THYM) (P = 0.017 and HR = 8.4 for OS).